Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00327600
Recruitment Status : Completed
First Posted : May 18, 2006
Last Update Posted : September 15, 2010
Information provided by:
AmpliMed Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2007
  Actual Study Completion Date : December 2007